Zydus Lifesciences Limited (BOM:532321)

Zydus Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 4, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	937,257	891,926	1,013,630	497,549	356,774	451,368
Market Cap Growth	-1.40%	-12.01%	103.72%	39.46%	-20.96%	64.98%
Enterprise Value	990,812	892,181	1,022,435	525,557	387,118	504,363
Last Close Price	931.45	875.67	991.39	480.25	338.29	425.19
PE Ratio	19.05	19.71	26.26	25.38	7.95	21.16
PS Ratio	3.83	3.84	5.19	2.89	2.36	3.13
PB Ratio	3.34	3.38	4.59	2.53	1.87	3.02
P/TBV Ratio	10.04	5.76	8.48	4.28	3.40	7.04
P/FCF Ratio	36.93	17.61	44.27	30.01	39.56	18.50
P/OCF Ratio	22.62	13.16	31.71	18.50	16.95	13.70
EV/Sales Ratio	4.05	3.84	5.23	3.05	2.56	3.50
EV/EBITDA Ratio	14.13	13.06	19.45	14.87	12.21	14.77
EV/EBIT Ratio	16.42	14.97	22.53	18.42	15.65	18.44
EV/FCF Ratio	39.04	17.62	44.65	31.70	42.92	20.67
Debt / Equity Ratio	0.34	0.12	0.04	0.06	0.22	0.31
Debt / EBITDA Ratio	1.39	0.47	0.16	0.34	1.33	1.35
Debt / FCF Ratio	3.80	0.64	0.36	0.72	4.68	1.89
Asset Turnover	0.63	0.70	0.71	0.64	0.59	0.61
Inventory Turnover	1.64	1.77	1.87	1.81	1.64	1.64
Quick Ratio	1.27	1.12	1.30	1.05	0.96	0.57
Current Ratio	1.94	1.89	2.14	1.81	1.54	1.11
Return on Equity (ROE)	19.25%	19.28%	18.90%	10.82%	13.96%	16.91%
Return on Assets (ROA)	9.54%	11.21%	10.31%	6.66%	5.98%	7.19%
Return on Capital (ROIC)	12.04%	14.19%	12.95%	8.08%	7.22%	8.71%
Return on Capital Employed (ROCE)	16.00%	21.20%	19.00%	14.10%	12.40%	17.10%
Earnings Yield	5.25%	5.07%	3.81%	3.94%	12.58%	4.73%
FCF Yield	2.71%	5.68%	2.26%	3.33%	2.53%	5.41%
Dividend Yield	1.18%	1.26%	0.30%	1.25%	0.74%	0.82%
Payout Ratio	22.47%	6.68%	16.09%	13.63%	8.29%	0.07%
Buyback Yield / Dilution	0.27%	0.56%	0.37%	0.79%	-	-
Total Shareholder Return	1.44%	1.82%	0.67%	2.04%	0.74%	0.82%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.